Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, has released an updated edition of its “State of Rural Hospitals and Cardiovascular Care” report. The report is designed to assist rural healthcare leaders, policymakers, and community-based organizations in improving cardiovascular care quality and outcomes in underserved areas.
The updated report addresses critical challenges such as specialist and physician shortages, limited broadband access, and the higher cardiovascular disease risk observed among rural populations. It presents a revised four-part care model focusing on upskilling primary care clinicians, advancing care through epigenetic-genetic testing, implementing population-wide health strategies, and integrating remote care options in rural communities.
According to the company, the report also explores the role of technologies like virtual cardiac care and precision-medicine testing in strengthening early detection, improving access, and delivering personalized care. These tools are seen as essential to bridging the gap between rural and urban healthcare outcomes.
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that aims to make cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company leverages its proprietary AI-driven Integrated Genetic-Epigenetic Engine to develop and commercialize clinical tests. For more information about Cardio Diagnostics, visit its newsroom at https://ibn.fm/CDIO.
The full press release is available at https://ibn.fm/H28lM.
